[Detrusor pseudohyperactivity syndrome in children with constipation]

Ryszard Makosiej1, Danuta Leśniak, Ewa Skłodowska

  • 1Klinika Gastroenterologii, Instytut Centrum Zdrowia Matki Polki, ul. Rzgowska 281/289, 93-338 Lodz , Poland. kgp@iczmp.edu.pl

Medycyna Wieku Rozwojowego
|July 11, 2006
PubMed

Insights

Chronic constipation in children can lead to detrusor hyperactivity syndrome, causing nocturia and daytime urinary incontinence. This occurs due to rectal pressure on the bladder, impacting its volume and function.

Area of Science:

  • Pediatric Urology
  • Gastroenterology
  • Clinical Medicine

Background:

  • Nocturia, pressing tenesmus, and daytime urinary incontinence are common pediatric urological issues.
  • The interplay between constipation and lower urinary tract symptoms requires further investigation.

Purpose of the Study:

  • To evaluate the relationship between constipation and symptoms of nocturia, pressing tenesmus, and daytime urinary incontinence in children.
  • To understand the underlying mechanisms connecting constipation to these urinary symptoms.

Main Methods:

  • A study involving 51 children (3-17 years) hospitalized for nocturia, pressing tenesmus, and daytime urinary incontinence.
  • Comprehensive diagnostic workup of the urinary and lower alimentary tracts, with results compared to a control group.

Main Results:

  • An enlarged rectal ampulla can decrease bladder volume, leading to pressing tenesmus, nocturia, and daytime urinary incontinence.
  • This mechanism contributes to the development of detrusor hyperactivity syndrome, characterized by chronic constipation and altered voiding patterns.

Conclusions:

  • Chronic constipation disrupts the functional balance between the distal bowel and bladder.
  • This disruption contributes to the formation of detrusor hyperactivity syndrome, affecting urine storage and voiding.
Abstract

Related Concept Videos

The Micturition Reflex01:26

The Micturition Reflex

Urination, or micturition involves the coordination of the bladder's detrusor muscle and two sphincters to ensure controlled bladder emptying.
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating urine...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...